Company profile: Pyramid Laboratories
1.1 - Company Overview
Company description
- Provider of contract parenteral drug product manufacturing and analytical services for the pharmaceutical and biotechnology industries, including aseptic vial and syringe filling, lyophilization, formulation and process development, clinical supply manufacturing, commercial fill/finish, and labeling, storage, and global distribution.
Products and services
- Commercial Manufacturing: Delivers commercial-scale fill/finish for vial and syringe applications within a newly built, state-of-the-art commercial aseptic parenteral manufacturing facility
- Aseptic Filling: Engineers clinical-grade aseptic vial and syringe fills for pharmaceutical and biotechnology products, supporting both clinical and commercial manufacturing needs
- Pharmaceutical Lyophilization: Architects development-stage lyophilization to develop stable, lyophilized drug products that can be easily reconstituted and administered
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pyramid Laboratories
Cellumen
HQ: United States
Website
- Description: Provider of cellular systems biology solutions delivering accurate predictions of drug efficacy and safety to drive Discovery Toxicology and reduce failure rates and development costs. Offers biomarker analysis tools, including for COVID-19 and cardiac issues, cloning, assay kits (ELISA and protein), and cDNA for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellumen company profile →
Apicore
HQ: United States
Website
- Description: Provider of process R&D and active pharmaceutical ingredient (API) manufacturing services for the pharmaceutical industry worldwide, specializing in difficult-to-synthesize, high-value, and niche specialty APIs, serving customers in the generic medicine industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apicore company profile →
Syra Health
HQ: United States
Website
- Description: Provider of healthcare and managed-care solutions grounded in real-world evidence and insights, including a mental and behavioral health platform for assessments, education, symptom monitoring, and interventions; an EMR to streamline clinical workflows and manage patient health information; a real-time patient engagement bot; workforce staffing and MSPs; a population health insights hub; and education and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syra Health company profile →
Artes Biotechnology
HQ: Germany
Website
- Description: Provider of biopharmaceutical production processes and CDMO services, including microbial cell line and process development, manufacturing of test and preclinical material, and vaccine development. Offers pre-developed recombinant protein processes (biosimilars, vaccines, enzymes), technology transfer and proprietary cell line licensing; supplies recombinant reagents from yeast and bacterial platforms; and develops yeast (Hansenula polymorpha) and E. coli systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artes Biotechnology company profile →
Argon Network
HQ: United Kingdom
Website
- Description: Provider of an international network of independent healthcare agencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argon Network company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pyramid Laboratories
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pyramid Laboratories
2.2 - Growth funds investing in similar companies to Pyramid Laboratories
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pyramid Laboratories
4.2 - Public trading comparable groups for Pyramid Laboratories
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →